International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 4 (July-August 2026) Submit your research before last 3 days of August to publish your research paper in the issue of July-August.

Bidirectional Linkages Between Sarcopenia and Type 2 Diabetes Mellitus in Older Adults: Mechanisms, Clinical Implications, and Therapeutic Interventions

Author(s) Dr. JEEVA GEORGE, Dr. MOHAMMED KHAJA MOINUDEEN, Dr. ARSALAAN AHMAD KHAN, Ms. KHUSHI DINESH
Country India
Abstract Background: Sarcopenia and type 2 diabetes mellitus (T2DM) frequently coexist in the geriatric population, creating a synergistic pathological loop that accelerates functional decline, disability, and mortality. While T2DM impairs skeletal muscle quality and accelerates muscle mass loss through chronic low-grade inflammation, insulin resistance, and advanced glycation end-product (AGE) accumulation, sarcopenia exacerbates glycemic dysregulation by reducing the primary site of insulin-mediated glucose disposal.
Objective: This review explores the pathophysiological cross-talk between sarcopenia and T2DM, evaluates current diagnostic paradigms, assesses clinical consequences, and synthesizes evidence-based management strategies tailored for older adults.
Methods: A comprehensive literature review was performed utilizing major biomedical databases, synthesizing recent clinical trials, consensus guidelines, and mechanistic studies up to 2026.
Results: Sarcopo-diabetes—the concurrent presentation of sarcopenia and diabetes—amplifies the risk of cardiovascular disease, falls, and frailty compared to either condition alone. Diagnostic criteria require a tripartite evaluation of muscle mass, muscle strength, and physical performance. Management necessitates a multi-modal approach combining progressive resistance training (PRT), individualized nutritional optimization (higher protein targets with leucine supplementation), and pharmacological agents that preserve or enhance muscle mass (such as GLP-1 receptor agonists and SGLT2 inhibitors) while minimizing hypoglycemic events.
Conclusion: Early identification and integrated management of sarcopenia in older patients with T2DM are essential to preserve functional independence and mitigate metabolic morbidity.
Field Medical / Pharmacy
Published In Volume 8, Issue 4, July-August 2026
Published On 2026-08-08

Share this